Search Results

Policy

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.

June 25, 2024

·

6 min read

Deals

Merck Animal Health to Acquire Elanco’s Aqua Business

Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.

February 5, 2024

·

7 min read

Traffic light in green color, with the dusk sky in the background.

FDA

2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US

Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.

January 2, 2025

·

2 min read

·

Kate Goodwin

Pharm Country

Merck Animal Health’s Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration with the American Veterinary Medical Association.

January 15, 2024

·

12 min read

Aerial view of Gyles Quay, Dundalk, Louth, Ireland

Manufacturing

Merck Snaps Up WuXi Biologics Facility in Ireland for $500M

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.

January 6, 2025

·

1 min read

·

Annalee Armstrong

Pictured: Aerial view of the San Francisco skyline

Pipeline

JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year.

January 15, 2025

·

4 min read

·

Tristan Manalac

Press Releases

Atropos Health Collaborates with Merck for Rapid Evidence Generation to Accelerate Innovation for Life-Saving Treatments

January 10, 2025

·

3 min read

Press Releases

Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus

September 25, 2024

·

5 min read

Press Releases

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

January 7, 2025

·

5 min read

Postmarket research

Merck’s Former Asthma Blockbuster Singulair Could Be Linked to Mental Health Problems: Reuters

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma therapy montelukast to adverse neuropsychiatric effects.

November 22, 2024

·

2 min read

·

Tristan Manalac